Tang et al. demonstrated that the metabolic axis involving glutamine, proline, and hydroxyproline exerts its effects by modulating the activity of the HIF1a in HCC and contributing to resistance to the drug sorafenib [141]. This evidence concerns the gene HIF1A and hepatocellular carcinoma.